Type 2 Diabetes: CHMP recommends empagliflozin* for approval

Type 2 Diabetes: CHMP recommends empagliflozin* for approval

https://www.boehringer-ingelheim.com/press-release/type-2-diabetes-chmp-recommen...

Source: Boehringer Ingelheim Corporate News - July 25, 2016 Category: Research Source Type: news

More News: Diabetes | Diabetes Type 2 | Empagliflozin | Endocrinology | Jardiance | Research